|
HIV/Aids in Prison, Problems, Policies and Potential
KC Goyer
The
issue of HIV/AIDS in prisons has become an important topic
world-wide, both in countries where HIV prevalence is minimal
as well as where the impact of HIV is much more severe. In
March 1993, the World Health Organisation (WHO) distributed
guidelines on HIV infection and AIDS in prison. The guidelines
covered HIV testing, preventive measures, management and care
of HIV-infected prisoners, confidentiality, tuberculosis, and
early release policies. The general principle advocated by the
WHO is that of the ‘equivalence principle’:
All
prisoners have the right to receive health care, including
preventive measures, equivalent to that available in the
community without discrimination, in particular with respect
to their legal status or nationality. The general principles
adopted by a national AIDS programme should apply equally to
prisoners and to the community.134
The
WHO guidelines were publicly supported and endorsed by the
Joint United Nations Programme on HIV/AIDS (UNAIDS) in a
statement issued in April 1996. The UNAIDS statement explained
that ignorance and lack of government support in addressing
HIV/AIDS in prison has led to denial, ineffective policies,
violence and discrimination.135 Many different
policy options have been explored in response to HIV/AIDS in
prison with varying results in different countries and
contexts. However, an international consensus confirmed by the
WHO and UNAIDS has declared that some of the more popular
policies are not only ineffective but unnecessary and
unjustified. The policies which have been condemned by
international bodies include mandatory testing, and
segregation. Other policies employed in various prison systems
include education, condoms, disinfectant and sterilised
needles, and general penal reform.
Mandatory testing
The primary goal of most
policies regarding prisoners with HIV is to prevent
transmission either to inmates or prison staff. The most
severe policy combines mandatory mass testing and isolation of
HIV positive inmates. Testing for HIV is not entirely
straightforward, and complicates the effectiveness of this
policy. There is no such thing as an AIDS test, rather a
person is tested for the antibodies which the body develops in
response to HIV.
The most commonly used test in South Africa is the
enzyme-linked immunosorbent assay (ELISA) test. The
immunofluorescent antibody test, IFA or Western Blot, is also
used although it is usually more expensive and less sensitive.
No single test is 100% accurate. Researchers at the Medical
Research Council use a combination of three ELISA tests, each
with a varying degree of sensitivity, to weed out false
positives and guarantee more accurate results. Further
complicating the matter is the fact that sometimes the body
does not develop enough HIV antibodies to be detected by a
test for up to three months after infection. The result is
that if all prisoners are tested upon admission to the prison,
they must be tested again three months later to be assured of
the reliability of the results.
Assuming the resources were available for multiple testing,
both upon entrance and three months later, the concept of
involuntary testing runs into many legal and ethical
roadblocks. The WHO stresses that a prerequisite for any
medical intervention is the informed consent of the patient.
This doctrine of informed consent does not apply in
circumstances where the general health of society are at
stake. This is the case with a mass immunisation programme
intended to contain a contagious disease, such as small pox,
or standard testing in health facilities for highly contagious
diseases, such as TB.
The notable difference between HIV and either small pox or TB
is that HIV is not a contagious condition with the potential
to infect unprotected citizens. HIV is not transmitted through
casual contact, or by a person simply functioning in the
community. In fact, not one study has found a case in which
AIDS was transmitted, “through ordinary nonsexual contact in
a family, work, or social setting.”136
Furthermore, the effects of mandatory testing can have
far-reaching impacts on the lives of prisoners after release,
as they can potentially suffer from insurance or employment
discrimination. For these reasons, HIV cannot be compared to
TB or other curable medical conditions when discussing the
ethics versus necessity of mandatory HIV testing.
Detecting HIV as early as possible is the most cost-beneficial
means of providing treatment in prisons. The premise behind
this argument is that it is cheaper to prevent HIV from
developing into AIDS than it is to care for prisoners with
full-blown AIDS.137 However, this argument only
holds if prisoners who test positive for HIV will receive
treatment that can delay the onset of AIDS. Treatment of
opportunistic infections does not delay the progression of
HIV. Rather, ARV therapy and a high-protein diet can
accomplish this feat for many HIV positive patients. Unless a
standard of care can be provided to prisoners that will delay
the development of AIDS, one cannot use the argument for early
detection in support of a mandatory testing policy.
Proponents of mandatory mass testing argue that determining
exactly how many prisoners, and specifically which ones, are
HIV positive will enable correctional services to improve
care, target education programmes, gather information on
transmission, provide special supervision, and plan and budget
effectively for HIV-related programmes and policies.138
A further argument employed to support mandatory testing is
that voluntary testing will be ineffective, as a good portion
of inmates will not agree to participate. A survey conducted
in the US revealed that 85% of inmates would consent to a
voluntary HIV test, and 66% would voluntarily attend
counselling or education programmes.139 This
argument does not take into account the effectiveness of
statistical sampling techniques to determine HIV prevalence of
a specific population. Academic studies to determine HIV
prevalence frequently rely on randomly selected voluntary
participation, often with a sample size which consists of only
10% of the prisoners at a given correctional facility.
Assuming that the prison administration legitimately wishes
and is able to provide additional services and care for HIV
positive prisoners, a sample size which covers 85% of the
population would be more than adequate to make projections for
budget and programme planning purposes.
Segregation
Whether testing is
mandatory or voluntary, the issue of confidentiality is
important. In some instances, a prisoner’s HIV status is
disclosed discreetly to prison officials on a ‘need to
know’ basis, and in more extreme situations, prisoner cells
or files are clearly marked so that anyone who cared to know
would be aware of their HIV status. Maintaining
confidentiality of a prisoner’s HIV status is important
because of the social stigma associated with the disease. In
an independent report issued on the British prison system, the
importance of confidentiality was underlined, with the
understanding that, “HIV prisoners must not and need not
become the pariahs of the prison system”.140
Issues of confidentiality are usually not considered by those
proponents of mandatory testing who also argue for the
isolation or segregation of HIV positive prisoners. The
intention is that by identifying and separating HIV positive
prisoners, the prison will be able to provide increased health
monitoring, additional surveillance of high risk behaviour,
elimination of transmission within prison, and protection from
discrimination or violence from other inmates.141
There is a very real concern that not segregating HIV positive
inmates will lead to increased prison violence, in that HIV
prisoners will threaten cell mates with infection and other
prisoners will target HIV inmates for abuse. In this respect,
segregation is for the seropositive inmate’s protection as
much as it is for the protection of the general prison
population.
Some countries report considerable success with HIV
segregation programmes. In Poland, prisoners with HIV were
held on a separate, less crowded floor and allowed access to
more facilities, such as additional health care staff and
recreational activities. The general atmosphere was one of
support and specialised care, as opposed to the discrimination
and insults endured in the rest of the prison. In Polish
institutions where segregation was not initiated, prisoners
refused to share eating or toilet facilities, or even shake
hands with HIV positive prisoners. In some cases, medical
doctors would refuse assistance and encourage protest from the
staff against the non-segregation policy.142
The risk for abuse in a segregated system is great, as it is
conceivable that HIV positive inmates held in a separate
facility would be denied access to the same health, training,
and educational services that are available to the rest of the
prisoners. For this reason, proponents of segregation have
cautioned that segregation, “not be used a method of
punishment or as a means of reduction of care for inmates.”143
Rather, the idea is that appropriately implemented segregation
can have beneficial effects for all prisoners, whether HIV
positive or not. The argument is that “it is the negative
implementation of these programmes, not the concept of
segregation itself, that has prevented the success of
segregation.”144 On the other hand, the lessons
of history have shown us that regardless of the noblest
intentions of any segregation policy, the reality is that
‘separate but equal’ simply does not exist.
Segregation of HIV positive prisoners is a declining practice
in most countries. WHO guidelines explain that:
Since segregation,
isolation, and restrictions on occupational activities,
sports, and recreation are not considered useful or relevant
in the case of HIV negative infected people in the community,
the same attitude should be adopted towards HIV-infected
prisoners.145
Segregation is no longer
accepted as a sensible strategy because it contributes to the
stigmatisation of HIV positive people and presents numerous
logistical problems.146 Opponents of segregation
point out that even assuming equal treatment was maintained,
the result is a costly duplication of services which is
neither medically necessary nor reliably effective.
Although the philosophical arguments against segregation of
HIV positive prisoners are sound, the most convincing argument
is based on medical facts. As discussed previously, the
‘window period’ means that when a person first becomes
infected with HIV, he or she may test negative for HIV for
approximately three months. The duration of this window period
varies by person and is impossible to predict. To accommodate
this reality, prisoners would have to be tested upon entrance
and those who test negative would then have to be isolated in
an ‘undetermined status’ section for the first three
months of their incarceration. They would then have be tested
again after three months, and moved to either the ‘HIV’ or
‘non-HIV’ sections of the prison according to their
status. This means that recently-infected and non-HIV infected
prisoners could be confined together in the ‘undetermined
status’ section for the first three months.
The counter argument is that the number of recently-infected
prisoners who were in the window period upon entering the
prison would be much less than the number of prisoners who
were already HIV positive and so the policy would still
substantially reduce the risk of transmission. The rationale
is that it is better to only have a few who were recently
infected held in common with others for a little while, than
to have all the HIV positive prisoners intermixed with all the
other prisoners for the duration of incarceration.
This does not take into account that research has determined
that the viral load of an HIV positive person peaks in the
first few weeks after transmission, when the virus is still
undetectable because the body has not yet produced the
antibodies which are detected by an HIV test.147
Once the body begins to fight the virus by producing
sufficient antibodies, the viral load declines dramatically
and then only slowly creeps upwards over the next several
years. It is at this point that a person tests positive for
HIV because the test is able to detect the presence of HIV
antibodies in the person’s blood, urine, or saliva.
The probability of HIV transmission is related to a number of
factors, including viral load. If a person has a high viral
load, the probability of that person transmitting HIV is also
high.148 Thus, during the window period when viral
load is very high, a recently infected HIV positive prisoner
has a much greater probability of transmitting the virus. Add
on to this the fact that many prisoners in the ‘undetermined
status’ will have a false sense of security owing to the
fact that all of them have tested negative upon entry to the
prison and the known positives have already been segregated.
The result is the potential that every single HIV negative
prisoner could be confined for three months with HIV positive
prisoners who have a higher probability of transmitting the
virus than a good portion of those who have already tested
positive for HIV. Clearly, this would negate the intended
benefits of this policy and could possibly be
counter-productive.
Education
Both sides of the debate
on segregation agree that education is one of the most
important ingredients of an effective HIV/AIDS in prison
policy. However, HIV/AIDS education in the prison environment
presents specific challenges which are unlike those for the
general population. The personality profile of many prisoners
often includes a deep-seated suspicion of anything
‘official’ or government related, which can negate the
efforts of programmes which enjoyed significant success in the
general community.149
In addition, mass education programmes have not proven
effective at changing behaviour because they are not presented
in the context of specific lifestyles. The prisoners perceive
them as irrelevant and will not relate the information to
their own lives.150 Scare tactics have also proven
ineffective, and may possibly be counterproductive to the
extent that they elicit a denial response.151 Also,
prisoners in South Africa are normally members of the lower
socio-economic strata, and have had very little formal
education.152 Education materials must cater to the
wide diversity of languages spoken in prisons, and need also
take into account the low literacy rate of the prison
population.
The unfortunate truth is that an increase in HIV/AIDS related
knowledge is not always translated into altering or reducing
high risk behaviour.153 HIV/AIDS information needs
to be specifically targeted, and take into account the common
characteristics or lifestyles that put prisoners at risk for
HIV. The influence of peer groups has proven to be essential
in any successful intervention strategy as the credibility of
the communicator has a significant impact on the capacity of
the message to engender behavioural change. This credibility
should be determined within the context of the prison
population, because what might be valued by the average
citizen outside of the prison is not the same as that
appreciated by the average prisoner.154
The general consensus regarding peer education is that,
“accepted norms of the target group play a larger part in
influencing behaviour than does outside intervention by
authorities or health educators.”155
A study in Scotland attempted to determine the effectiveness
of two different HIV/AIDS education programmes, one designed
by prisoners and one designed by the state. The study found
that a video followed by a group discussion was the most
effective means of conveying information about HIV/AIDS to
prisoners. Two videos were shown in the study. One, “AIDS: A
Bad Way to Die”, was put together by prisoners at Sing Sing
prison in New York City and the other was produced by the
British government. The prisoners in the survey responded
significantly better to the New York video, which featured
three actual prisoners who spoke about how they contracted
HIV, how it affected their lives and their families, and also
discussed their symptoms.
In addition to the prisoners’ stories, the video showed
medical experts who discussed transmission precautions and
also emphasised that HIV cannot be transmitted by casual
contact. The video concluded with each of the three
prisoners’ death from AIDS. In the discussion groups which
followed, prisoners filled out questionnaires to asses the
impact of the video. The study found that of the prisoners who
watched the New York video, more than 90% responded that they
would stop sharing or would try to sterilise injection
equipment and the same percentage also claimed that they would
use condoms.156
Condoms
A policy to distribute
condoms in prison is often very controversial because
government officials do not wish to discuss homosexual
activity in prisons, and a good portion deny that any such
activity takes place at all. If sex is thought a taboo subject
even in a modern democracy, homosexual activity is even more
often considered not a topic fit for parliamentary debate. In
some countries, condoms are not available in prison because
top prison officials either refuse to acknowledge that
homosexual activity takes place or have set regulations which
forbid such activity in their correctional facilities. The
argument is then that condom distribution would compromise the
authority and security of the prison because it implicitly
condones an activity which is prohibited.
However, this is a relatively minor obstacle compared to the
significant number of countries which outlaw homosexual
activity in the general population. In Malawi’s prisons,
where HIV prevalence and the incidence of homosexual activity
are both high, condoms are not available. Any attempts to
introduce a condom distribution policy must first deal with
the fact that homosexual activity is illegal in Malawi.
Described as an “unnatural offence” in the Malawi Penal
Code, conviction results in a prison sentence of 14 years.157
One reason that prison officials may not be willing to admit
that sex takes place in prison is because then they would be
forced to address the increased risk of HIV transmission
created by the unprotected sexual activities of inmates. With
the understanding that many prisoners are not willing to
disclose their participation in homosexual activities, the
policy recommended by UNAIDS is to provide “discreet and
easy access to condoms.”158
Because sex in prison is primarily anal sex between men, it is
also important to make lubricant available. One reason that
receptive anal intercourse carries the highest probability of
HIV transmission is because of the attendant tearing in the
rectum.159 Not only can this tearing be reduced by
using lubrication, but the likelihood that a condom will break
during anal intercourse is also reduced by the presence of
appropriate lubrication. In France, condoms and lubricant are
available, and are placed “in open containers in reception,
the health care centre, and other locations where potential
users…have the opportunity to take them unobserved.”160
Disinfectants and sterilised needles
Use of contaminated
cutting or piercing instruments has been shown to be a high
risk behaviour for transmitting HIV in prisons, particularly
in the case of sharing needles for IV drug use. Distributing
sterilisation tablets, or bleach, to prisoners is a policy
that is gaining popularity in countries where IV drug use is a
primary means of transmission.
At Hindlebank women’s prison in Switzerland, a one year
experimental project provided sterile needles to the 100
inmates, most of whom were convicted of drug offences. The
sterile needles were available from dispensing machines in
accessible locations, such as toilets, showers and storage
areas. Prisoners were not permitted to keep more than one
needle and were required to store their injecting equipment in
a designated cabinet. An evaluation of the project found that
there were no new cases of HIV, prisoner health had improved,
needle-sharing decreased, drug use remained stable, and there
were no instances of needles being used as weapons. At the end
of the year, the project was considered a success and was
continued.161
Rather than provide sterile needles, a more popular approach
to the problem of shared IV drug use equipment is to provide
sterilisation materials for the inmates. This policy meets
with similar arguments as the condom distribution policy,
citing the principle that providing bleach or other
disinfectants implies approval of illegal or prohibited
activities. Nonetheless, an increasing number of prison
systems are introducing bleach distribution programmes. In
Spain, a bottle of bleach is provided to each prisoner upon
entry into prison and each month thereafter, in addition to
being available as needed. Other countries which distribute
bleach to a similar extent include Australia, Belgium, Canada,
France, Germany, the Netherlands, and Luxembourg.162
The arguments against providing disinfectant materials for
prisoners are that it is not necessary or that the
disinfectant will be used as a weapon or in some other manner
that would constitute a threat to security. After a bleach
distribution pilot project in Canada, an evaluation
questionnaire found that 99% of respondents felt that having
bleach available to inmates is “very important” and all
but one injecting drug user responded that they would use
bleach to sterilise injecting equipment.163
According to Ralf Jürgens of the Canadian HIV/AIDS Legal
Network, “There are no reported incidents of any negative
consequences of making bleach available. This is consistent
with the Canadian experience.”164
HIV treatment
The recommended treatment
for HIV is anti-retroviral (ARV) therapy. This is a
combination of several drugs, which usually must be taken at
different times with various specific directions as to
accompaniment with meals or fluids and other such
requirements. ARV treatment is complicated and expensive, and
the prison environment poses serious challenges to its
effectiveness. The administration of the complicated treatment
regime is usually the realm of specialists, and not something
a typical prison health facility is able to provide. In
addition, the lack of privacy intrinsic to any prison
situation means that a prisoner undergoing ARV treatment will
have difficultly concealing his or her HIV status from prison
officials or other prisoners.
ARV treatment is not available from state hospitals in South
Africa. Although the drama is currently unfolding as the South
African government is pressured to roll out a national
treatment plan including the use of lower cost generic drugs,
it is still not likely that these will be made universally
available to the extent that access would be extended to
prisoners in the near future.
Some of the arguments in favor of a national treatment plan
include the premise that providing treatment will help to
reduce transmission, and that targeted education accompanied
by political leadership and a multi-level multi-sectoral
commitment will reduce if not eliminate concerns about regimen
adherence. The prisons are an excellent opportunity to apply
these recommendations with maximum effect. If ARV is extended
to the general community, but not to prisoners, then the
effectivness of any universal treatment plan will be gravely
endangered.
In the absence of ARV therapy, the recommended treatment for
HIV positive individuals is “symptomatic management” of
the disease.165 This usually requires treating and
preventing the more common opportunistic infections associated
with HIV, namely pneumonia and TB. Both of these illnesses can
be cheaply treated and even prevented. Prison hospitals
normally administer INH and Bactrim for HIV positive patients,
but their supplies are sometimes changed and interrupted as a
result of unreliable distribution services.166
Consistent and continued doses as part of the prescription
programme for TB is extremely important because non-adherence
to the treatment regime can result in treatment resistance.
Those who develop a treatment resistant strain of TB can
infect others, who will then also not be cured by the usual
drug treatments. Multi-drug resistant tuberculosis (MDRTB) is
much more difficult to cure, the required medicines are more
expensive and have deleterious side effects. MDRTB can result
in death if treatment is not available.167 For
these reasons, it is critical that prison administrations
implement appropriate policies to ensure that TB medicine is
both consistently and readily available and that sufficient
health staff are on hand to ensure treatment adherence.
Early release
WHO guidelines advocate
early release of prisoners in the advanced stages of AIDS. The
motivation behind a policy of early release is to allow a
person to die in dignity, either in their own home or with
their family, rather than forcing them to die isolated and
alone in prison.
Italian law prevents anyone with overt AIDS from being held in
prison custody. The definition of ‘overt AIDS’ is
clinically established as a patient whose number of T/CD4+
lymphocytes are equal to or lower than 100/mmc. To determine
this, the prisoner is administered two consecutive tests, 15
days apart.168 Other alternatives suggest that
prisoners with AIDS be released from prison but held under
house arrest, admitted to a public health institution, or that
the sentence be remitted indefinitely.
There are some unintended consequences of establishing an
early release programme for prison inmates with AIDS. In
Poland, a policy was adopted very early on which allowed AIDS
prisoners to be released and transferred to an open hospital.
The unfortunate result was that prisoners began to buy
infected blood from HIV positive prisoners in the hope of
getting released.169 A particularly disturbing
report describes a prisoner who traded a pack of cigarettes
and some tea for an inch of HIV positive blood. When he
couldn’t find a vein with the borrowed syringe, he was
worried he wouldn’t become infected and so he asked for
another inch of infected blood in order to be sure. His
actions were encouraged by an HIV positive inmate who assured
him that HIV positive status was a guaranteed way to be
released from prison.170
|
|
|
|
|
NOTES
HIV/Aids in Prison, Problems, Policies and Potential
KC Goyer
1.
Department of Correctional Services, Official
Statistics, Pretoria, June 2002.
2.
A Whiteside and G Wood, AIDS in KwaZulu-Natal:
An Emerging Threat, KwaZulu-Natal Briefing, The
Helen Suzman Foundation, Johannesburg, December 1996, p
1.
3.
UNAIDS, Consultation on STD interventions for
preventing HIV: what is the evidence? UNAIDS,
Geneva, Switzerland, 2000, pp 7–8.
4.
United Nations Development Program, HIV/AIDS
and Human Development, South Africa, UNAIDS and UNDP,
1998.
5.
UNAIDS, Epidemiological Fact Sheets on
HIV/AIDS and sexually transmitted infections: South
Africa, UNAIDS, 2000, pp 7–8.
6.
UNDP, op cit, pp 52–3.
7.
MetLife, Doyle Model, Scenario 225,
Available from HEARD, University of Natal, Durban, April
2000.
8.
UNDP, op cit, p 55.
9.
Department of Correctional Services, Official
Statistics, Pretoria, February 2001.
10.
LS Shain, DA Wohl, BL Stephenson, MS Adamian, CB
Emrick, RP Strauss, C Golin and A Kaplan, Sexual and
drug related risky behaviors among HIV positive
individuals following release from prisons in North
Carolina, Paper presented at XIV International HIV/AIDS
Conference, Barcelona, Spain, 2002.
11.
Ibid.
12.
DW Seal, AD Margolis, D Binson, KM Morrow, GD
Eldridge, D Kacanek, L Belcher, JM Sosman & Project
START,HIV, STD, and hepatitis risk behavior among
18–29 year old men incarcerated in the United States,
Presentation at the XIV International AIDS Conference,
Barcelona, July, 2002.
13.
Ibid.
14.
DR Tourinho & I Dourado, Safe sex in the
prison system in Salvador, Brazil: It is possible?,
Abstract presented at the XIV International AIDS
Conference, Barcelona, July 2002.
15.
Ibid.
16.
Ibid.
17.
A Morozov and AN Fridman, HIV testing,
prevalence, and risk behaviors among prisoners
incarcerated in St Petersburg, Russia, Paper presented
at the XIII International AIDS Conference, Durban, July,
2000.
18.
M Bijl and L Frost, Public health rationale for
MSF’s prison HIV/AIDS prevention pilot program in the
Russian Federation, Paper presented at XIII
International AIDS Conference, Durban, July, 2000.
19.
L Moriarty and C Fields, Is the Segregation of
HIV-positive Inmates Ethical?, Prison Journal
79(1), March 1999, p 11.
20.
Ibid.
21.
PA Thomas and M Moerings (eds), AIDS in Prison,
Darmouth Publishing Company Ltd, Hants, England, 1994, p
111.
22.
Ibid, p 112.
23.
HIV soars in prison inmates, Hamilton
Spectator, Canada, 16 November 2000.
24.
Ibid.
25.
DL Yirrell, D Robertson, DJ Goldberg, J McMenamin,
S Cameron, AJ Leigh-Brown, Molecular Investigation into
Outbreak of HIV in a Scottish Prison, British Medical
Journal, 314(1446), May 17, 1997, p 1.
26.
National AIDS & Prisons Forum (NAPF), Press
Release, 20 July 1998, p 1.
27.
PA Thomas and M Moerings, op cit, p 47.
28.
Ibid.
29.
Prison ‘turning inmates into heroin addicts’,
The Independent, 1 May 1998, p 1.
30.
Ibid.
31.
JJ Neser and M Pretorius, AIDS in Prisons, Acta
Criminologica, 6(1), 1993, p 24.
32.
L Highelyman, Sexual Transmission in the Era of
New Treatments, Bulletin of Experimental Treatments
for AIDS, San Francisco AIDS Foundation, July 1999,
p 1.
33.
M Carelse, AIDS Prevention and High Risk
Behaviour in Juvenile Correctional Institutions,
University of Western Cape, Bellville, 1994, p 5.
34.
Understanding HIV/AIDS, AIDS Toolkits,
Bureau for Africa, Office of Sustainable Development,
USAID, 1999, p 1.
35.
World Bank, Confronting AIDS, Oxford
University Press, 1997, p 59.
36.
Highleyman, op cit, p 3.
37.
S Gear, An Uncomfortable, Unspeakable Truth, Mail
& Guardian, No 25, May 2001, p 2.
38.
Thomas, op cit, p 49.
39.
Ibid, p 47.
40.
Ibid, p 49.
41.
S Donaldson, Encyclopedia of Homosexuality,
Garland Public, New York, 1990, p 4.
42.
Ibid, p 11.
43.
Ibid, p 12.
44.
M Jolofani, AIDS in Prison in Malawi,
Penal Reform International, Paris, 1999, p 8.
45.
Ibid, p 7.
46.
Ibid, p 8.
47.
Ibid, p 9.
48.
Ibid.
49.
Ibid.
50.
Ibid, p 10.
51.
Ibid, p 11.
52.
Ibid, p 16.
53.
Moriarty and Fields, op cit, p 5.
54.
Ibid.
55.
V Stern, A Sin Against the Future:
Imprisonment in the World, Penguin Books, London,
1998, p 13.
56.
M Carelse, op cit, p 8.
57.
USAID, op cit.
58.
V Stern, op cit, p 17.
59.
As quoted in V Stern, op cit, p 18.
60.
MA Nikitina, Effective Approaches to HIV/AIDS
Prevention and the Protection of Rights of HIV positive
Prison Inmates in the Russian Federation, Paper
presented at XIV International HIV/AIDS Conference,
Barcelona, Spain, 2002.
61.
A Rakhmanova, GV Volkova, AA Yakouleu, LN Krvga,
NA Chaka, VR Shelukhina, EN Vinogradova, HIV in St.
Petersburg, Paper presented at XIII International AIDS
Conference, Durban, 2000.
62.
Ibid.
63.
HIV/AIDS Education in Prison Project (HEPP),
Brown University, HEPP News 3(7/8), July/August
2000, p 1.
64.
CDC Website, 1999
65.
AIDS Info (New York) <
66.
Thomas, op cit, p 141.
67.
AIDS Law website <
68.
NAPF, op cit, p 1.
69.
Thomas, op cit, p 140.
70.
SG Nagaraj, M Sarvade, L Muthanna, R Raju, S Aju,
and NM Sarvade, HIV seroprevalance and prevalent
attitudes amongst the prisoners: A case study in Mysore,
Karnataka state India, Paper presented at XIII
International AIDS Conference, Durban, July 2000.
71.
Department of Correctional Services, Annual
Report, Pretoria, 1999, p 19.
72.
UNAIDS, Epidemiological Fact Sheets on
HIV/AIDS and sexually transmitted infections, op
cit, p 3.
73.
Office of the Inspecting Judge, Annual Report
2000: Prisons and Prisoners, Judicial Inspectorate,
Cape Town, 31 January 2001, p 19.
74.
Office of the Inspecting Judge, Study of AIDS
Related Deaths in Prison, Judicial Inspectorate,
Cape Town, 2000.
75.
Correctional Services Dispute HIV/Aids Statistics
in Prisons, BuaNews, Pretoria, May 24, 2002.
76.
Ibid.
77.
Fagan Comes in for Stick in Committee About Aids
Claims, South African Press Association,
Johannesburg, May 28, 2002.
78.
Ibid.
79.
Correctional Services Dispute HIV/Aids Statistics
in Prisons, op cit.
80.
Westville Medium B Records Department, Report on
prisoners admitted during 2001, obtained 26 January
2002.
81.
UNDP, op cit, p 57.
82.
Ibid, p 57.
83.
Ibid, p 24.
84.
Westville Medium B Records Department, op cit.
85.
R Dorrington and L Johnson, The Ingredients
and Impact of the HIV/AIDS Epidemic in South Africa and
its Provinces, UNICEF Global Study For the South
African Case Study of the Impact of HIV/AIDS on
Children, Health Economics & HIV/AIDS Research
Division (HEARD), University of Natal, Durban, May 2001,
p 5.
86.
Ibid.
87.
Department of Correctional Services, Official
Statistics, Pretoria, February 2001.
88.
Actuarial Scientists Association of South Africa
(ASSA), Actuarial Projection of the Epidemic,
2000,
89.
Interview #10 with Ted Leggett, Institute for
Security Studies (at the time he was editor of Crime
& Conflict), 6 March 2001 at the University of
Natal, Durban.
90.
Ibid.
91.
Ibid.
92.
Interview #7 with Former Prisoner, 16 March 2001
at the University of Natal, Durban.
93.
UNDP, op cit, p 50.
94.
Carelse, op cit, p 7.
95.
Interview #10, op cit.
96.
Drawn from the results of a prisoner study and
reported in detail in KC Goyer, HIV/AIDS in South
Africa: A Policy Analysis, submitted for Master’s
degree, University of Natal, Durban, June 2001.
97.
Neser, op cit, p 24.
98.
Highleyman, op cit, p 1.
99.
Interview #4 with Westville Medium B Social
Worker X, 20 April 2001 at Westville Medium B.
100.Ibid.
101.Interview
#10, op cit.
102.Interview
#8 with Derrick Mdluli, President, South African
Prisoners Organisation for Human Rights (SAPOHR), 16
March 2001 at the SAPOHR Durban office.
103.C
Giffard, Out of Step? The Transformation Process in
the South African Department of Correctional Sercices,
Institute of Criminology, University of Cape Town, 1999,
p 36.
104.AIDS-Linked
Deaths in South African Prisons Soar, Agence France
Presse, 10/17/00,
105.Interview
#6 with Westville Medium B Social Worker Z, 20 April
2001 at Westville Medium B.
106.T
Farren, Worst nightmare: Prison rape, Mail &
Guardian, May 19–25, 2000, p 33.
107.C
Greene, HIV positive in Prison: The Shadow of Death
Row, October/November 1996,
108.Moriarty
and Fields, op cit, p 3.
109.Thomas,
op cit, p 97.
110.Moriarty
and Fields, op cit, p 5.
111.KC
Goyer, HIV/AIDS in South Africa: A Policy Analysis,
submitted for Master’s degree, University of Natal,
Durban, June 2001.
112.Thomas,
op cit, p 38.
113.Carelse,
op cit, p 27.
114.Thomas,
op cit, p 32.
115.Moriarity
1999: 2
116.Interview
#7, op cit.
117.Ibid.
118.Interview
#3 with Westville Medium B Health Staff C, 29 March 2001
at Westville Medium B.
119.Interview
#7, op cit.
120.Interview
#1 with Westville Medium B Health Staff A, 29 March 2001
at Westville Medium B; Interview #2 with Westville
Medium B Health Staff B, 29 March 2001 at Westville
Medium B; Interview #4, op cit.
121.Interview
#7, op cit.
122.Good
Nutrition May Delay Onset of AIDS, United Press
International, San Francisco, 25 October 1993.
123.Interview
#5 with Westville Medium B Social Worker Y, 20 April
2001 at Westville Medium B; Interview #6, op cit.
124.Interview
#5, op cit.
125.Thomas,
op cit, p 97.
126.Interview
#7, op cit.
127.Ibid.
128.Interview
#4, op cit.
129.Ibid.
130.N
Haysom, Towards an Understanding of Prison Gangs,
Institute of Criminology, University of Cape Town, 1981,
p 4.
131.Interview
#10, op cit.
132.Interview
#4, op cit.
133.Interview
#7, op cit.
134.World
Health Organisation (WHO), Guidelines on HIV
Infection and AIDS in Prisons. Geneva, March 1993.
135.UNAIDS,
Statement to the UN Commission on Human Rights,
April 1996.
136.PJJ
Pienaar, AIDS and the Criminal Justice Officer, Acta
Criminologica, 2(1), 1989, p 89.
137.Moriarty
and Fields, op cit, p 4.
138.Neser,
op cit, p 28.
139.Moriarty
and Fields, op cit, p 4.
140.Thomas,
op cit, p 52.
141.Moriarty
and Fields, op cit, p 3.
142.Thomas,
op cit, p 34.
143.Moriarty
and Fields, op cit, p 4.
144.Ibid,
p 3.
145.WHO,
op cit, p 27.
146.Moriarty
and Fields, op cit, p 7.
147.JA
Jacquez, JS Koopman, CP Simon, IM Longini, Role of the
primary infection in epidemics of HIV infection in gay
cohorts, Journal of Acquired Immune Deficiency
Syndrome, 7(1169–1184), 1994, p 1169.
148.PL
Vernazza, JJ Eron, SA Fiscus, MS Cohen, Sexual
Transmission of HIV: infectiousness and prevention, Journal
of Acquired Immune Deficiency Syndrome,
13(155–166), 1999, p 157.
149.Thomas,
op cit, p 36.
150.Carelse,
op cit, p 13.
151.Ibid,
p 14.
152.J
Van Heerden, Prison Health Care in South Africa,
University of Cape Town, 1996, p 2.
153.Carelse,
op cit, p 12.
154.Carelse,
op cit, p 14.
155.Carelse,
op cit, p 15.
156.Scottish
Prison Service (SPS), HIV/AIDS in Prison, SPS
Occasional Papers Report No 1, 1994, p 36.
157.Jolofani,
op cit, p 7.
158.UNAIDS
Technical Update, HIV/AIDS in Prison, UNAIDS,
1997, p 2.
159.Highleyman,
op cit, p 3.
160.S
Shaw, Sex, Drugs, and the Fight Against AIDS, Prison
Report, Issue No 32, 1999, p 1.
161.UNAIDS
Technical Update, op cit, p 5.
162.R Jürgens,
HIV/AIDS in Prison: Final Report, Canadian
HIV/AIDS Legal Network, Montreal, 1996, p 2.
163.Ibid.
164.Ibid.
165.A
Whiteside & C Sunter, AIDS: The Challenge for
South Africa, Human & Rousseau, Tafelberg,Cape
Town, 2000.
166.Interview
#2, op cit.
167.V
Stern (ed), Sentenced to Die? The problem of TB in
prisons in Eastern Europe and Central Asia,
International Centre for Prison Studies, Kings College,
London, 1999, p 17.
168.Thomas,
op cit, p 88.
169.Ibid,
p 35.
170.Ibid,
p 36.
171.Z
Achmat, and M Heywood, The Weakest Amongst Us: Managing
HIV in South African Prisons, Imbizo, Issue 2,
1996, p 13.
172.Department
of Correctional Services, Handling Strategy: AIDS in
Prisons, Pretoria, 1992, p 2.
173.ASSA,
op cit.
174.Department
of Correctional Services, Handling Strategy: AIDS in
Prisons, Pretoria, 1992, p 4.
175.Ibid,
p 2.
176.Ibid,
p 5.
177.Giffard,
op cit, p 41.
178.Department
of Correctional Services, White Paper on the Policy
of the Department of Correcional Services in the New
South Africa, Pretoria, October 1994, p 8.
179.Ibid,
p 10.
180.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Desegregation of Prisoners with AIDS/HIV,
Pretoria, 17 May 1996.
181.Ibid.
182.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Provision of Condoms to the Prison
Population, Pretoria, 17 May 1996.
183.Ibid.
184.Ibid.
185.Ibid.
186.Ibid.
187.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Desegregation of Prisoners with AIDS/HIV,
Pretoria, 17 May 1996.
188.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Provision of Condoms to the Prison
Population, Pretoria, 17 May 1996.
189.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Desegregation of Prisoners with AIDS/HIV,
Pretoria, 17 May 1996.
190.Interview
#3, op cit.
191.Interview
#1, op cit.
192.Ibid.
193.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Desegregation of Prisoners with AIDS/HIV,
Pretoria, 17 May 1996.
194.Ibid,
p 10.
195.Interview
#1, op cit.
196.Ibid.
197.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Provision of Condoms to the Prison
Population, Pretoria, 17 May 1996, p 1.
198.Ibid.
199.KC
Goyer, HIV/AIDS in South Africa: A Policy Analysis,
submitted for Master’s degree, University of Natal,
Durban, June 2001.
200.Interview
#2, op cit.
201.R Jürgens,
HIV/AIDS in Prison: Final Report, Canadian
HIV/AIDS Legal Network, Montreal, 1996, p 2.
202.Moriarty
and Fields, op cit, p 5.
203.PW
v The Minister of Correctional Services, 1997.
204.Ibid.
205.PW
v The Minister of Correctional Services, 1998.
206.PW
v The Minister of Correctional Services, 1997.
207.Department
of Correctional Services, Management Strategy: AIDS
in Prisons: Desegregation of Prisoners with AIDS/HIV,
Pretoria, 17 May 1996, pp 6–7.
208.Department
of Correctional Services, Official Statistics, Pretoria,
June 2000.
209.Interview
#1, op cit.
210.Interview
#5, op cit.
211.Interview
#4, op cit.
212.Ibid.
213.WHO,
op cit, p 9.
214.Interview
#4, op cit.
215.Ibid.
216.Interview
#2, op cit.
217.Interview
#4, op cit.
218.Office
of the Inspecting Judge, Annual Report 2000: Prisons
and Prisoners, op cit, p 17.
219.Interview
#11 with Chris Giffard, Centre for Conflict Resolution
(CCR) (at the time of the interview working for Centre
for the Study of Violence and Reconciliation), 7 March
2001 at Pollsmoor Prison, Western Cape.
220.UNAIDS
Technical Update, op cit, p 4.
221.V
Stern (ed), Sentenced to Die? The problem of TB in
prisons in Eastern Europe and Central Asia, op cit,
p 21.
222.Thomas,
op cit, p 36.
223.Carelse,
op cit, p 13.
224.Ibid,
p 14.
225.Ibid,
p 12.
226.Carelse,
op cit, p 14.
227.Ibid,
p 15.
228.Achmat
and Heywood, op cit.
229.Giffard,
op cit.
230.Ibid.
231.Department
of Correctional Services, Official Statistics, Pretoria,
February 2001.
232.T Hammett, Prevention and
Treatment of HIV/AIDS and Other Infectious Diseases in
Correctional Settings: An Opportunity Not Yet Seized, HIV
Education Prison Project (HEPP) News, Brown
University, 1999, p 1.
|
|
|
|
|
|
|
|
|